Twelve-month treatment with Liraglutide ameliorates Visceral Adiposity Index and common cardiovascular risk factors in type 2 diabetes outpatients
Crossref DOI link: https://doi.org/10.1007/s40618-014-0163-9
Published Online: 2014-08-31
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Russo, G. T.
Labate, A. M.
Giandalia, A.
Romeo, E. L.
Villari, P.
Alibrandi, A.
Perdichizzi, G.
Cucinotta, D.
Text and Data Mining valid from 2014-08-31